139 related articles for article (PubMed ID: 3063480)
1. Marked digoxin-like immunoreactive factor interference with an enzyme immunoassay.
Karboski JA; Godley PJ; Frohna PA; Horton MW; Reitmeyer WJ
Drug Intell Clin Pharm; 1988 Sep; 22(9):703-5. PubMed ID: 3063480
[TBL] [Abstract][Full Text] [Related]
2. A physician's office-based digoxin assay (Seralyzer) evaluated for interference by endogenous digoxin-like immunoreactive factors.
Matheke ML; Valdes R
Ann Clin Lab Sci; 1989; 19(3):168-74. PubMed ID: 2658726
[TBL] [Abstract][Full Text] [Related]
3. Endogenous digoxin-like immunoreactive factors (DLIF) as measured by the CEDIA digoxin assay and a fluorescence polarization immunoassay.
Schlebusch H; Jarausch J; Domke I
Wien Klin Wochenschr Suppl; 1992; 191():59-66. PubMed ID: 1509757
[TBL] [Abstract][Full Text] [Related]
4. Interference of endogenous digoxin-like immunoreactive factors in serum digoxin measurement is minimized in a new turbidimetric digoxin immunoassay on ADVIA 1650 analyzer.
Datta P; Dasgupta A
Ther Drug Monit; 2004 Feb; 26(1):85-9. PubMed ID: 14749555
[TBL] [Abstract][Full Text] [Related]
5. Digoxin-like immunoreactivity in serum from neonates and infants reduced by centrifugal ultrafiltration and fluorescence polarization immunoassay.
Ray JE; Crisan D; Howrie DL
Clin Chem; 1991 Jan; 37(1):94-8. PubMed ID: 1988216
[TBL] [Abstract][Full Text] [Related]
6. New enzyme-linked immunosorbent digoxin assay on the ADVIA IMS 800i system is virtually free from interference of endogenous digoxin-like immunoreactive factors.
Dasgupta A; Kang E; Datta P
Ther Drug Monit; 2005 Apr; 27(2):139-43. PubMed ID: 15795642
[TBL] [Abstract][Full Text] [Related]
7. Effect of antibody specificity on results of selected digoxin immunoassays among various clinical groups.
Datta P; Xu L; Malik S; Landicho D; Ferreri L; Halverson K; Roby PV; Zebelman AM; Kenny MA
Clin Chem; 1996 Mar; 42(3):373-9. PubMed ID: 8598098
[TBL] [Abstract][Full Text] [Related]
8. Methods for eliminating interferences in digoxin immunoassays caused by digoxin-like factors.
Graves SW; Sharma K; Chandler AB
Clin Chem; 1986 Aug; 32(8):1506-9. PubMed ID: 3755385
[TBL] [Abstract][Full Text] [Related]
9. Endogenous digoxin-like immunoreactive factors eliminated from serum samples by hydrophobic silica-gel extraction and enzyme immunoassay.
Skogen WF; Rea MR; Valdes R
Clin Chem; 1987 Mar; 33(3):401-4. PubMed ID: 3545537
[TBL] [Abstract][Full Text] [Related]
10. Improved interassay correlation of digoxin results in patients with and without renal failure by elimination of digoxin-like immunoreactive factors.
Skogen WF; Rea MR; Valdes R
Clin Chem; 1987 Jun; 33(6):837-9. PubMed ID: 3594830
[TBL] [Abstract][Full Text] [Related]
11. Digoxin-like immunoreactive substance in renal failure: a reappraisal.
Greenway DC; Nanji AA
Nephron; 1986; 44(2):108-10. PubMed ID: 3774074
[TBL] [Abstract][Full Text] [Related]
12. Treatment of human serum with sulfosalicylic acid structurally alters digoxin and endogenous digoxin-like immunoreactive factor.
Qazzaz HM; Goudy S; Miller JJ; Valdes R
Ther Drug Monit; 1995 Feb; 17(1):53-9. PubMed ID: 7725377
[TBL] [Abstract][Full Text] [Related]
13. Comparison of free digoxin and total digoxin: extent of interference from digoxin-like immunoreactive substances (DLIS) in a fluorescence polarization assay.
Dasgupta A; Nakamura A; Doria L; Dennen D
Clin Chem; 1989 Feb; 35(2):323-4. PubMed ID: 2914387
[No Abstract] [Full Text] [Related]
14. Interference of digoxin-like immunoreactive substances with three digoxin immunoassays in patients with various degrees of renal function.
Pleasants RA; Gadsden RH; McCormack JP; Piveral K; Sawyer WT
Clin Pharm; 1986 Oct; 5(10):810-6. PubMed ID: 3780148
[TBL] [Abstract][Full Text] [Related]
15. Temperature-dependent immunoreactive assay to screen for digoxin-like immunoreactive factor(s).
Guédeney X; Chanez C; Grenier A; Scherrmann JM
Clin Chem; 1991 Nov; 37(11):1900-4. PubMed ID: 1718632
[TBL] [Abstract][Full Text] [Related]
16. Improving the specificity of digoxin immunoassays.
Valdes R
Wien Klin Wochenschr Suppl; 1992; 191():55-9. PubMed ID: 1509756
[TBL] [Abstract][Full Text] [Related]
17. Tentative identification of a digoxin-like immunoreactive substance.
Toseland PA; Oldfield PR; Murphy GM; Lawson AM
Ther Drug Monit; 1988; 10(2):168-71. PubMed ID: 3381233
[TBL] [Abstract][Full Text] [Related]
18. Radioimmunoassay of digoxin in serum using monoclonal antibodies and assessment of interference by digoxin-like immunoreactive substances.
Loucari-Yiannakou E; Yiannakou L; Souvatzoglou A; Diamandis EP
Ther Drug Monit; 1990 Mar; 12(2):195-200. PubMed ID: 2315977
[TBL] [Abstract][Full Text] [Related]
19. [High digoxin serum levels in an elderly patient for the endogenous digoxin-like immunoreactive substances. A case report].
Suppa M; Giancaspro G; Coppola A; Colzi M; Marini ME; Magnanelli E; Baldini E; Cavicchi F; Petroni C; Contu E; Boccardo C; Scarpellini MG
Clin Ter; 2011; 162(3):245-8. PubMed ID: 21717052
[TBL] [Abstract][Full Text] [Related]
20. Interference from digitoxin-like immunoreactive factors reduced in a new monoclonal chemiluminescent digitoxin assay.
Datta P; Dasgupta A
Ther Drug Monit; 1998 Dec; 20(6):663-8. PubMed ID: 9853984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
